TORTI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 2.274
EU - Europa 995
AS - Asia 691
OC - Oceania 11
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 3.985
Nazione #
US - Stati Uniti d'America 2.237
CN - Cina 404
IT - Italia 245
IE - Irlanda 126
DE - Germania 106
SE - Svezia 83
FR - Francia 81
JP - Giappone 66
FI - Finlandia 61
AT - Austria 58
GB - Regno Unito 57
SG - Singapore 55
PL - Polonia 43
UA - Ucraina 41
KR - Corea 33
IN - India 31
CA - Canada 29
VN - Vietnam 27
HK - Hong Kong 22
BE - Belgio 14
RU - Federazione Russa 13
TR - Turchia 13
ES - Italia 11
AU - Australia 10
CH - Svizzera 10
NL - Olanda 9
TW - Taiwan 9
DK - Danimarca 7
IR - Iran 7
MX - Messico 6
TH - Thailandia 6
RO - Romania 5
HU - Ungheria 4
SN - Senegal 4
CZ - Repubblica Ceca 3
EE - Estonia 3
EU - Europa 3
GR - Grecia 3
IQ - Iraq 3
LK - Sri Lanka 3
MO - Macao, regione amministrativa speciale della Cina 3
ZA - Sudafrica 3
BG - Bulgaria 2
BR - Brasile 2
ID - Indonesia 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
AZ - Azerbaigian 1
CO - Colombia 1
IL - Israele 1
IM - Isola di Man 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SI - Slovenia 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 3.985
Città #
Chandler 299
Fairfield 244
Ann Arbor 190
Beijing 171
Ashburn 133
Dublin 122
Woodbridge 120
Houston 106
Seattle 101
Wilmington 100
Cambridge 76
Torino 74
Dearborn 61
Villeurbanne 60
Pisa 58
Vienna 58
Nyköping 57
Fremont 39
Jacksonville 38
Warsaw 36
Princeton 31
Shanghai 31
Singapore 28
Medford 22
Dong Ket 21
Redwood City 20
Tokyo 18
Guangzhou 16
Los Angeles 16
New York 16
Boardman 15
Boston 14
Nanjing 14
Brussels 13
Hong Kong 13
Ottawa 12
San Diego 12
Hangzhou 10
Milan 10
Turin 10
London 9
Norwalk 9
Shenzhen 9
Taipei 9
Changsha 8
Falls Church 8
Helsinki 8
Munich 8
Paris 8
Zhengzhou 8
Silver Spring 7
Toronto 7
Amsterdam 6
Duncan 6
Düsseldorf 6
Manchester 6
Rome 6
Washington 6
Wuhan 6
Zurich 6
Buffalo 5
Chengdu 5
Fuzhou 5
Genoa 5
Hefei 5
Phoenix 5
Bangkok 4
Chatsworth 4
Delhi 4
Galway 4
Gurgaon 4
Jinan 4
Luni 4
San Mateo 4
Tehran 4
Ankara 3
Austin 3
Barcelona 3
Central 3
Columbus 3
Dallas 3
Horana South 3
Kocaeli 3
Kolkata 3
Madison 3
Marlborough 3
Montreal 3
Mountain View 3
Nanchang 3
Piemonte 3
Qingdao 3
San Jose 3
Seoul 3
Suzhou 3
Tallinn 3
Arbil 2
Athens 2
Awaji 2
Bar Harbor 2
Bengaluru 2
Totale 2.767
Nome #
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 607
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 319
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 314
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 301
Only a subset of Met-activated pathways are required to sustain oncogene addiction 237
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 225
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. 207
Inhibition of Src impairs the growth of met-addicted gastric tumors. 201
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias 171
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia 169
Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils 154
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 115
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. 112
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion 98
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 92
Diffusion-weighted quantitative MRI to diagnose benign conditions from malignancies of the anterior mediastinum: Improvement of diagnostic accuracy by comparing perfusion-free to perfusion-sensitive measurements of the apparent diffusion coefficient 91
MET SIGNALING REGULATES GROWTH, REPOPULATING POTENTIAL AND BASAL CELL-FATE COMMITMENT OF MAMMARY LUMINAL PROGENITORS: IMPLICATIONS FOR BASAL-LIKE BREAST CANCER. 83
INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS 80
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY 75
Met as a potential therapeutic target in basal-like breast cancer: An in vivo approach in a stem-cell perspective 73
Met as a potential therapeutic target in basal-like breast cancer 71
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia 69
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition 67
A case report of narrowing primary tracheal mucosa‑associated lymphoid tissue lymphoma: A multidisciplinary approach 54
The Role of PTEN in Myeloid Malignancies 50
Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia 50
RNA sequencing analysis in primary mediastina B cell lymphoma: identification of different gene expression related to chemoresistance 13
Totale 4.098
Categoria #
all - tutte 9.196
article - articoli 0
book - libri 0
conference - conferenze 2.692
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.888


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020627 55 22 31 95 45 90 74 46 61 43 34 31
2020/2021533 37 38 43 18 37 82 76 23 43 36 38 62
2021/2022577 47 47 23 45 22 30 36 40 32 45 116 94
2022/2023773 77 74 32 83 51 171 42 60 78 16 53 36
2023/2024465 42 51 35 32 32 57 30 37 11 35 61 42
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 4.098